Add Yahoo as a preferred source to see more of our stories on Google. An Ohio University researcher is leading a study that could pave the way for new treatments to prevent dangerous infections in ...
A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...
University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during ...
— Greg Vigna, M.D., J.D. SANTA BARBARA, CA, UNITED STATES, August 3, 2023/EINPresswire.com/ -- “Prolonged IV antibiotics are necessary for the treatment of Grade ...
The bacterium Clostridioides difficile is named “difficult” for a reason. Originally, it was hard to grow in the lab, and, now, it’s the source of gut infections that are tough to treat. About half a ...
Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...
Clostridium difficile caused nearly half a million infections in U.S. patients in 2011, and C. diff infections kill roughly 15,000 Americans each year, according to the Centers for Disease Control and ...
An Ohio University researcher is leading a study that could pave the way for new treatments to prevent dangerous infections in heart failure patients. The American Heart Association has awarded a ...
A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results